A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma | PLOS ONE
![SciELO - Brasil - Sequential allocation to balance prognostic factors in a psychiatric clinical trial Sequential allocation to balance prognostic factors in a psychiatric clinical trial SciELO - Brasil - Sequential allocation to balance prognostic factors in a psychiatric clinical trial Sequential allocation to balance prognostic factors in a psychiatric clinical trial](https://minio.scielo.br/documentstore/1980-5322/PDWnPMnmcqrvQfYvmmNRqHg/29957eedb6ca7a390195be68632519ffd5899b9c.gif)
SciELO - Brasil - Sequential allocation to balance prognostic factors in a psychiatric clinical trial Sequential allocation to balance prognostic factors in a psychiatric clinical trial
![Endotronix on Twitter: "We are excited to announce that we've received FDA approval of our IDE amendment to shift the PROACTIVE-HF Clinical Trial to a single-arm design. Learn more: https://t.co/dwWJKKjc2t #heartfailure #telemedicine # Endotronix on Twitter: "We are excited to announce that we've received FDA approval of our IDE amendment to shift the PROACTIVE-HF Clinical Trial to a single-arm design. Learn more: https://t.co/dwWJKKjc2t #heartfailure #telemedicine #](https://pbs.twimg.com/media/FIWXjrEWQAEAWkM.jpg:large)
Endotronix on Twitter: "We are excited to announce that we've received FDA approval of our IDE amendment to shift the PROACTIVE-HF Clinical Trial to a single-arm design. Learn more: https://t.co/dwWJKKjc2t #heartfailure #telemedicine #
![A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors - Gynecologic Oncology A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a21f53db-0abc-4750-a49e-547f5732b6d3/gr1.jpg)
A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors - Gynecologic Oncology
![Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/73f2df0d-0edd-4eba-a066-3225d572b5a7/gr1.jpg)
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology
![Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/47854562-24b8-4be4-8132-a630f7adeeba/gr3.jpg)
Biomarker Clinical Trials in Lung Cancer: Design, Logistics, Challenges, and Practical Considerations - Journal of Thoracic Oncology
![Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol](https://bmjopen.bmj.com/content/bmjopen/3/7/e002902/F1.large.jpg?width=800&height=600&carousel=1)
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
![Mixed response and time-to-event endpoints for multistage single-arm phase II design – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub. Mixed response and time-to-event endpoints for multistage single-arm phase II design – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.](https://cyberleninka.org/viewer_images/601124/f/1.png)
Mixed response and time-to-event endpoints for multistage single-arm phase II design – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
![Nikhil Krishnan on Twitter: "5/ RWE enables a lot of interesting new trial designs including -Single arm trials + synthetic control arms -Pragmatic trials (combining RCT with RWE) -Adaptive trial design (e.g. Nikhil Krishnan on Twitter: "5/ RWE enables a lot of interesting new trial designs including -Single arm trials + synthetic control arms -Pragmatic trials (combining RCT with RWE) -Adaptive trial design (e.g.](https://pbs.twimg.com/media/EVQJnuWWAAEgNMd.png:large)
Nikhil Krishnan on Twitter: "5/ RWE enables a lot of interesting new trial designs including -Single arm trials + synthetic control arms -Pragmatic trials (combining RCT with RWE) -Adaptive trial design (e.g.
Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease | PLOS Medicine
![START Monitoring Substudy design schema. Of 239 clinical trial sites... | Download Scientific Diagram START Monitoring Substudy design schema. Of 239 clinical trial sites... | Download Scientific Diagram](https://www.researchgate.net/profile/Jonathan-Kagan-2/publication/276359818/figure/fig1/AS:788906748436481@1565101434992/START-Monitoring-Substudy-design-schema-Of-239-clinical-trial-sites-registered-for-the.png)